New study reveals 5 ways to reduce high blood pressure
The University of Calgary’s Cumming School of Medicine recently revealed a study that shows the act of treating high blood pressure throughout Canada eat up about 10 percent of the country’s health-care budget.
In fact, just in 2010 alone, the federal government spent USD$13.9 billion treating the various symptoms and consequences of this condition. Unfortunately, these numbers are only continuing to rise and show no sign of slowing down any time soon.
Click here to read the latest edition of Healthcare Global magazine!
Originally reported by our sister brand Business Review Canada, nine out of 10 people will develop high blood pressure during their lives. Specifically, if nothing is done to stop this epidemic, Canadian taxpayers could pay more than USD$20 billion by 2020 on this disease.
It’s a well-known fact that blood pressure can be caused by a variety of factors; one of the main roots is stress. If you have a particularly high-charged career in which you’re consistently feeling overwhelmed or strained, then you could be at risk for developing high blood pressure.
To stop the problem before it begins (or to maybe get a handle on the issue), we’ve put together a list of lifestyle changes that can help you avoid this growing disease.
1. Watch your weight
As your weight increases, so can your blood pressure. Working 12+ hour days may not leave much room for exercising or eating healthy, but it’s vital to take care of yourself and to be mindful of your state of health.
RELATED TOPIC: Improving Canada’s health system in 4 ways
Weight loss is one of the most effective lifestyle changes for controlling blood pressure. In fact, just losing 10 pounds can help reduce your blood pressure. Therefore, make time to exercise regularly and eat healthy. Avoid the convenience of fat, greasy foods.
2. Don’t consume too much sodium
One of the main components to eating healthy is to avoid or reduce your sodium intake. Even the smallest reduction of sodium in your diet can reduce your blood pressure by 2 to 8 mm Hg.
There are different ways you can accomplish this goal such as reading food labels, eating fewer processed foods and by not adding table salt to your meal.
3. Limit the amount of alcohol you drink
If you happened to have a particlualry stressful day at the office, you may choose to unwind with a cocktail—watch how many you throw back.
Sure, in small amounts, alcohol can potentially lower your blood pressure by 2 to 4mm Hg. However, if you drink too much, then alcohol can have the opposite effect. Drinking more than moderate amounts of alcohol can actually raise blood pressure by several points, as well as reduce the effectiveness of blood pressure medications.
The same can also be said for caffeine—what the amount you put into your body on a daily basis.
4. Quit smoking cigarettes
If you’re a smoker, stop! Each cigarette you smoke increases your blood pressure for many minutes after you finish it. Quitting smoking can actually help your blood pressure return to normal, as well as potentially increase your life expectancy.
5. Rid yourself of stressful situations
And finally, if your life is stressful, it’s imperative to rid yourself of these situations. After all, stress can lead to eating poorly, consuming more alcohol and smoking more cigarettes—all triggers of high blood pressure.
Determine what factors in your life are particularly stressful, and then find ways to eliminate stress from these areas. You may need to change your expectations, learn your stress triggers or make significant time to relax and take part in activities that you enjoy.
If you don’t take care of yourself, then who will? There’s no time like the present to take control of your body and health and start making a difference. After all, you only get one life—don’t waste it!
Bachem turns 50 - a timeline
Bachem, a supplier to pharmaceutical and biotechnology companies worldwide, is celebrating its 50th anniversary this month. We take a look at the Swiss company's history.
1971 - beginnings
Bachem is founded by entrepreneur Peter Grogg in Liestal, a small town near Basel in Switzerland. Grogg started the firm with just two employees, and with a focus on peptide synthesis - peptides are composed of amino acids that have a variety of functions treating health conditions such as cancer and diabetes.
1977 - 1981 - early growth
Bachem moves its headquarters to the Swiss town of Bubendorf, with eight employees. In 1978 the company produces peptides for use in medicines for the first time. In 1981 production capacity triples and the workforce grows to 150.
1987 - 1996 - worldwide expansion
The company expands into the US with Bachem Bioscience, Inc. in Philadelphia. To strengthen its presence in Europe, Bachem opens sales and marketing centres in Germany in 1988.
Further sales centres open in France in 1993. By 1995 the company employs 190 people. In 1996 it acquires the second largest manufacturer of peptides in the world and forms Bachem California with a site in Torrance.
1998 - 2003 - Bachem goes public
Bachem company goes public and lists shares on the Swiss Stock Exchange. Further acquisitions include Peninsula Laboratories, Inc, based in California, and Sochinaz SA, a Swiss-based manufacturer of active pharmaceutical ingredients. By 2001, the company has 500 employees and sales reach 141 million CHF.
In 2003 the organisation is given a new legal holding structure to support its continued growth, which remains in place to this day.
2007 - 2013 - acquisitions
Bachem acquires a brand by Merck Biosciences for ready-to-use clinical trial materials and related services.
In 2013, together with GlyTech, Inc. Bachem announces the development of a new amino acid that can help to treat multiple sclerosis, with a world market of more than $4 billion.
In 2015 it acquires the American Peptide Company (APC), which becomes integrated into Bachem Americas.
2016 - 2019 - a global leader
In 2016 the group opens a new building dedicated to R&D projects and small series production in Bubendorf. With a total of 1,022 employees, the workforce exceeds the 1,000 mark for the first time in the company’s history. Sales are over the 200 million mark for the first time at 236.5 million CHF.
Bachem expands into Asia with the establishment of a new company in Tokyo called Bachem Japan K.K.
By 2019 Bachem has a growing oligonucleotide portfolio - these are DNA molecules used in genetic testing, research, and forensics. It is hoped this will become a significant product range in the future.
2020 - COVID-19
Despite the COVID-19 pandemic, Bachem secures its supply of active ingredients, and even increases it in critical areas. Sales exceed the 400 million Swiss franc mark for the first time, and 272 new employees are hired.
2021 - a milestone anniversary
Bachem celebrates its 50th anniversary and position as a global leader in the manufacture of peptides. While it remains headquartered in Bubendorf, the company employs 1,500 people at six locations worldwide. In the next five years there are plans to continue expanding.
Commemorating the company's anniversary, Kuno Sommer, Chairman of the Board of Directors, said: "Bachem's exceptional success story from a small laboratory to a global market leader is closely linked to Peter Grogg's values, and has been shaped by innovation, consistent quality and cost awareness, as well as by entrepreneurial vision."